The application of genome-wide 5-hydroxymethylcytosine studies in cancer research
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The application of genome-wide 5-hydroxymethylcytosine studies in cancer research
Authors
Keywords
-
Journal
Epigenomics
Volume 9, Issue 1, Pages 77-91
Publisher
Future Medicine Ltd
Online
2016-12-12
DOI
10.2217/epi-2016-0122
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Loss of Tet1-Associated 5-Hydroxymethylcytosine Is Concomitant with Aberrant Promoter Hypermethylation in Liver Cancer
- (2016) J. P. Thomson et al. CANCER RESEARCH
- Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing
- (2016) Angelo Amabile et al. CELL
- Role of TET enzymes in DNA methylation, development, and cancer
- (2016) Kasper Dindler Rasmussen et al. GENES & DEVELOPMENT
- Enhancer methylation dynamics contribute to cancer plasticity and patient mortality
- (2016) Rachel E. Bell et al. GENOME RESEARCH
- Whole-genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver
- (2016) Xin Li et al. GENOME RESEARCH
- Tumour hypoxia causes DNA hypermethylation by reducing TET activity
- (2016) Bernard Thienpont et al. NATURE
- Landscape of somatic mutations in 560 breast cancer whole-genome sequences
- (2016) Serena Nik-Zainal et al. NATURE
- Active DNA demethylation at enhancers during the vertebrate phylotypic period
- (2016) Ozren Bogdanović et al. NATURE GENETICS
- Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
- (2016) Andrew P. Feinberg et al. NATURE REVIEWS GENETICS
- Coming of age: ten years of next-generation sequencing technologies
- (2016) Sara Goodwin et al. NATURE REVIEWS GENETICS
- 5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomas
- (2016) Feng Zhang et al. Scientific Reports
- 5-Hydroxymethylcytosine Remodeling Precedes Lineage Specification during Differentiation of Human CD4 + T Cells
- (2016) Colm E. Nestor et al. Cell Reports
- Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells
- (2016) Matteo Forloni et al. Cell Reports
- Mapping of Variable DNA Methylation Across Multiple Cell Types Defines a Dynamic Regulatory Landscape of the Human Genome
- (2016) Junchen Gu et al. G3-Genes Genomes Genetics
- Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers
- (2016) Lili Li et al. Scientific Reports
- Hypermethylation of TET1 Promoter Is a New Diagnosic Marker for Breast Cancer Metastasis
- (2015) Yi Sang et al. Asian Pacific Journal of Cancer Prevention
- Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer
- (2015) N. Ichimura et al. Cancer Prevention Research
- Hypoxia Drives Breast Tumor Malignancy through a TET–TNFα–p38–MAPK Signaling Axis
- (2015) Min-Zu Wu et al. CANCER RESEARCH
- DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts
- (2015) David Roulois et al. CELL
- Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
- (2015) Katherine B. Chiappinelli et al. CELL
- Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer
- (2015) Ke Chen et al. CELL RESEARCH
- CCN4/WISP1 (WNT1 inducible signaling pathway protein 1): A focus on its role in cancer
- (2015) Irem Gurbuz et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- TET1 is a tumor suppressor of hematopoietic malignancy
- (2015) Luisa Cimmino et al. NATURE IMMUNOLOGY
- Single-Base Resolution Analysis of 5-Formyl and 5-Carboxyl Cytosine Reveals Promoter DNA Methylation Dynamics
- (2015) Francesco Neri et al. Cell Reports
- High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer
- (2015) Siri H. Strand et al. Clinical Epigenetics
- Epigenetic reprogramming of melanoma cells by vitamin C treatment
- (2015) Christopher B Gustafson et al. Clinical Epigenetics
- An integrative pan-cancer-wide analysis of epigenetic enzymes reveals universal patterns of epigenomic deregulation in cancer
- (2015) Zhen Yang et al. GENOME BIOLOGY
- Oxidative DNA demethylation mediated by Tet enzymes
- (2015) Guo-Liang Xu et al. National Science Review
- Characterization of acute myeloid leukemia based on levels of global hydroxymethylation
- (2014) L. I. Kroeze et al. BLOOD
- Active and Passive Demethylation of Male and Female Pronuclear DNA in the Mammalian Zygote
- (2014) Fan Guo et al. Cell Stem Cell
- Loss of 5-hydroxymethylcytosine in cancer: Cause or consequence?
- (2014) Gabriella Ficz et al. GENOMICS
- Decrease of 5-hydroxymethylcytosine in rat liver with subchronic exposure to genotoxic carcinogens riddelliine and aristolochic acid
- (2014) Christine Guo Lian et al. MOLECULAR CARCINOGENESIS
- The BRAF Oncoprotein Functions through the Transcriptional Repressor MAFG to Mediate the CpG Island Methylator Phenotype
- (2014) Minggang Fang et al. MOLECULAR CELL
- 5mC Oxidation by Tet2 Modulates Enhancer Activity and Timing of Transcriptome Reprogramming during Differentiation
- (2014) Gary C. Hon et al. MOLECULAR CELL
- 5-Hydroxymethylcytosine is a predominantly stable DNA modification
- (2014) Martin Bachman et al. Nature Chemistry
- BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence
- (2014) Lei Gu et al. NATURE GENETICS
- TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway
- (2014) F Neri et al. ONCOGENE
- A global assessment of cancer genomic alterations in epigenetic mechanisms
- (2014) Muhammad A Shah et al. Epigenetics & Chromatin
- Suppression of TET1-Dependent DNA Demethylation Is Essential for KRAS-Mediated Transformation
- (2014) Bo-Kuan Wu et al. Cell Reports
- DNA Hydroxymethylation Profiling Reveals that WT1 Mutations Result in Loss of TET2 Function in Acute Myeloid Leukemia
- (2014) Raajit Rampal et al. Cell Reports
- Modules, networks and systems medicine for understanding disease and aiding diagnosis
- (2014) Mika Gustafsson et al. Genome Medicine
- A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype
- (2014) Ryan W Serra et al. eLife
- Is DNA methylation of tumour suppressor genes epigenetic?
- (2014) Kevin Struhl eLife
- Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells
- (2014) Emily L Putiri et al. GENOME BIOLOGY
- Genomic insights into cancer-associated aberrant CpG island hypermethylation
- (2013) D. Sproul et al. Briefings in Functional Genomics
- SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
- (2013) Eric Letouzé et al. CANCER CELL
- Genome-wide Analysis Reveals TET- and TDG-Dependent 5-Methylcytosine Oxidation Dynamics
- (2013) Li Shen et al. CELL
- Decreased 5-Hydroxymethylcytosine (5-hmC) is an Independent Poor Prognostic Factor in Gastric Cancer Patients
- (2013) Qi Yang et al. Journal of Biomedical Nanotechnology
- Ascorbic Acid Enhances Tet-Mediated 5-Methylcytosine Oxidation and Promotes DNA Demethylation in Mammals
- (2013) Ruichuan Yin et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma
- (2013) Thilo Gambichler et al. MELANOMA RESEARCH
- Epigenetic profiles as defined signatures of xenobiotic exposure
- (2013) John P. Thomson et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- Oxidative bisulfite sequencing of 5-methylcytosine and 5-hydroxymethylcytosine
- (2013) Michael J Booth et al. Nature Protocols
- Comparative analysis of affinity-based 5-hydroxymethylation enrichment techniques
- (2013) John P. Thomson et al. NUCLEIC ACIDS RESEARCH
- Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver
- (2013) John P. Thomson et al. NUCLEIC ACIDS RESEARCH
- Decrease of 5-Hydroxymethylcytosine Is Associated with Progression of Hepatocellular Carcinoma through Downregulation of TET1
- (2013) Chungang Liu et al. PLoS One
- 5-hydroxymethylcytosine profiling as an indicator of cellular state
- (2013) Alexander Laird et al. Epigenomics
- Lsh regulates LTR retrotransposon repression independently of Dnmt3b function
- (2013) Donncha S Dunican et al. GENOME BIOLOGY
- Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation
- (2012) Yotaro Kudo et al. CANCER SCIENCE
- Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
- (2012) Christine Guo Lian et al. CELL
- Base-Resolution Analysis of 5-Hydroxymethylcytosine in the Mammalian Genome
- (2012) Miao Yu et al. CELL
- Promoter DNA methylation couples genome-defence mechanisms to epigenetic reprogramming in the mouse germline
- (2012) J. A. Hackett et al. DEVELOPMENT
- Mapping recently identified nucleotide variants in the genome and transcriptome
- (2012) Chun-Xiao Song et al. NATURE BIOTECHNOLOGY
- Decreased 5-Hydroxymethylcytosine Is Associated with Neural Progenitor Phenotype in Normal Brain and Shorter Survival in Malignant Glioma
- (2012) Brent A. Orr et al. PLoS One
- Alterations of metabolic genes and metabolites in cancer
- (2012) Eric K. Oermann et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Identification of Dlk1-Dio3 Imprinted Gene Cluster Noncoding RNAs as Novel Candidate Biomarkers for Liver Tumor Promotion
- (2012) Harri Lempiäinen et al. TOXICOLOGICAL SCIENCES
- Non-genotoxic carcinogen exposure induces defined changes in the 5-hydroxymethylome
- (2012) John P Thomson et al. GENOME BIOLOGY
- Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns
- (2012) Duncan Sproul et al. GENOME BIOLOGY
- 5-Hydroxymethylcytosine Is Strongly Depleted in Human Cancers but Its Levels Do Not Correlate with IDH1 Mutations
- (2011) S.-G. Jin et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Tet1 Is Dispensable for Maintaining Pluripotency and Its Loss Is Compatible with Embryonic and Postnatal Development
- (2011) Meelad M. Dawlaty et al. Cell Stem Cell
- Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes
- (2011) C. E. Nestor et al. GENOME RESEARCH
- Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer
- (2011) D. Sproul et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA
- (2011) Y.-F. He et al. SCIENCE
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
- (2010) Maria E. Figueroa et al. CANCER CELL
- Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
- (2010) Gillian L. Dalgliesh et al. NATURE
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- (2010) S. A. Forbes et al. NUCLEIC ACIDS RESEARCH
- The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores
- (2009) Rafael A Irizarry et al. NATURE GENETICS
- Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
- (2009) M. Tahiliani et al. SCIENCE
- The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain
- (2009) S. Kriaucionis et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started